Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (88)
NICE advice (1)
Guidance programme
Guidance programme
Clinical guidelines (20)
COVID-19 rapid guidelines (1)
Diagnostics guidance (8)
Health technology evaluations (5)
Highly specialised technologies guidance (2)
Interventional procedures guidance (6)
Medical technologies guidance (2)
NICE guidelines (25)
Technology appraisal guidance (40)
Advice programme
Advice programme
Evidence summaries (1)
Apply filters
Showing 1 to 50 of 89
Sort by
Date
Title
Apply sorting
Last updated date between: 1/3/2024 and 30/9/2024
Remove Last updated date between: 1/3/2024 and 30/9/2024 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Non-indicator text resource
CG1027
19 September 2024
19 September 2024
Test Syndication - IFP
NG295
16 September 2024
16 September 2024
MLB test IFP resource for syndication
NG296
16 September 2024
16 September 2024
HTE temp withdrawn
HST120
9 September 2024
9 September 2024
Temp Withdrawn Test
CG203
1 August 2024
1 August 2024
Master test-639
NG243
25 July 2024
25 July 2024
Claire test
CG8923
17 July 2024
17 July 2024
PUB602 pretest
NG242
15 July 2024
15 July 2024
Master new feeds test
CG273
11 July 2024
11 July 2024
NG Pdf test
NG275
9 July 2024
9 July 2024
Test Product 554
CG272
8 July 2024
8 July 2024
Test Product 554
DG65
8 July 2024
8 July 2024
Test PUB636
CG200
5 July 2024
5 July 2024
DG test -636
DG92
5 July 2024
5 July 2024
PUB550 test
CG279
3 July 2024
3 July 2024
PUB550 test
CG197
3 July 2024
3 July 2024
DG Content Order test
DG95
2 July 2024
2 July 2024
Content Order test
CG199
1 July 2024
1 July 2024
Master test-552
DG91
28 June 2024
28 June 2024
PUB-552 test
DG90
26 June 2024
26 June 2024
Master Pub test
CG195
25 June 2024
25 June 2024
Conversion word test
CG194
25 June 2024
25 June 2024
PUB-545 Resource Type test
DG59
21 June 2024
21 June 2024
Minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgus
IPG789
20 June 2024
20 June 2024
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy
TA984
19 June 2024
19 June 2024
Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal)
TA982
13 June 2024
13 June 2024
Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma
TA983
12 June 2024
12 June 2024
Voxelotor for treating haemolytic anaemia caused by sickle cell disease
TA981
12 June 2024
12 June 2024
Nivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal)
TA980
5 June 2024
5 June 2024
Ivosidenib with azacitidine for untreated acute myeloid leukaemia with an IDH1 R132 mutation
TA979
5 June 2024
5 June 2024
Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (terminated appraisal)
TA978
29 May 2024
29 May 2024
Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over
TA977
29 May 2024
29 May 2024
Trastuzumab deruxtecan for treating HER2-mutated advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)
TA976
29 May 2024
29 May 2024
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome
HST31
22 May 2024
22 May 2024
Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal)
TA972
22 May 2024
22 May 2024
Cladribine for treating relapsing–remitting multiple sclerosis
TA616
19 December 2019
21 May 2024
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis
TA312
28 May 2014
21 May 2024
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis
TA127
22 August 2007
21 May 2024
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
TA298
27 November 2013
20 May 2024
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion
TA283
22 May 2013
20 May 2024
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
TA155
27 August 2008
20 May 2024
Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes
IPG787
16 May 2024
16 May 2024
Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver
IPG786
16 May 2024
16 May 2024
Image-guided percutaneous laser ablation for primary and secondary liver tumours
IPG788
16 May 2024
16 May 2024
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and under
TA975
15 May 2024
15 May 2024
Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma
TA974
15 May 2024
15 May 2024
Atogepant for preventing migraine
TA973
15 May 2024
15 May 2024
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer
DG58
9 May 2024
9 May 2024
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19
TA971
8 May 2024
8 May 2024
Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments
TA970
8 May 2024
8 May 2024
Current page
1
2
Page
1
of
2
Next page
Results per page
10
25
50
All
Back to top